Our PPI network analysis identified key interactions between HLA-DRB5 and CD244, as well as HSD17B13 and CD244, as potential therapeutic targets in LUAD, with these genes showing downregulation in tumor tissues. This evidence concerns the gene CD244 and neoplasm.